Aflac (AFL) Projected to Post Quarterly Earnings on Wednesday

Aflac (NYSE:AFL) will likely be announcing its Q4 2025 Pre Recorded results after the market closes on Wednesday, February 4th. Analysts expect Aflac to post earnings of $1.72 per share and revenue of $4.4543 billion for the quarter. Parties are encouraged to explore the company’s upcoming Q4 2025 Pre Recorded earning overview page for the latest details on the call scheduled for Wednesday, February 4, 2026 at 8:00 AM ET.

Aflac (NYSE:AFL) last announced its earnings results on Tuesday, November 4th. The financial services provider reported $2.49 EPS for the quarter, beating analysts’ consensus estimates of $1.77 by $0.72. Aflac had a return on equity of 14.97% and a net margin of 23.55%.The firm had revenue of $4.41 billion for the quarter, compared to analysts’ expectations of $4.36 billion. During the same quarter in the prior year, the firm earned $2.16 EPS. Aflac’s quarterly revenue was up 59.4% on a year-over-year basis. On average, analysts expect Aflac to post $7 EPS for the current fiscal year and $7 EPS for the next fiscal year.

Aflac Price Performance

AFL opened at $108.39 on Wednesday. The company has a debt-to-equity ratio of 0.30, a quick ratio of 0.11 and a current ratio of 0.11. The stock has a market capitalization of $56.81 billion, a PE ratio of 14.15, a P/E/G ratio of 3.22 and a beta of 0.67. The company’s 50 day simple moving average is $109.76 and its 200 day simple moving average is $108.12. Aflac has a 1 year low of $96.95 and a 1 year high of $115.83.

Aflac Increases Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Monday, March 2nd. Investors of record on Wednesday, February 18th will be paid a dividend of $0.61 per share. This represents a $2.44 annualized dividend and a yield of 2.3%. This is a positive change from Aflac’s previous quarterly dividend of $0.58. The ex-dividend date is Wednesday, February 18th. Aflac’s dividend payout ratio (DPR) is currently 30.29%.

Analyst Ratings Changes

A number of brokerages recently issued reports on AFL. Piper Sandler set a $125.00 target price on Aflac and gave the stock an “overweight” rating in a report on Tuesday, October 7th. Wells Fargo & Company upped their price target on Aflac from $107.00 to $109.00 and gave the stock an “equal weight” rating in a report on Friday, November 7th. Mizuho initiated coverage on shares of Aflac in a report on Tuesday, December 16th. They issued an “underperform” rating and a $104.00 price target on the stock. Raymond James Financial reaffirmed an “outperform” rating and set a $119.00 price objective (up from $110.00) on shares of Aflac in a research note on Tuesday, December 30th. Finally, JPMorgan Chase & Co. raised their price target on shares of Aflac from $101.00 to $105.00 and gave the company a “neutral” rating in a report on Monday, January 5th. Three research analysts have rated the stock with a Buy rating, six have issued a Hold rating and three have issued a Sell rating to the company. According to MarketBeat, the company presently has a consensus rating of “Hold” and a consensus target price of $110.64.

Insider Buying and Selling

In related news, EVP Frederic Jean Guy Simard sold 1,722 shares of the stock in a transaction on Thursday, November 6th. The shares were sold at an average price of $112.50, for a total transaction of $193,725.00. Following the transaction, the executive vice president directly owned 1,364 shares of the company’s stock, valued at $153,450. This represents a 55.80% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, Director Joseph L. Moskowitz sold 786 shares of the company’s stock in a transaction on Monday, November 17th. The stock was sold at an average price of $113.75, for a total value of $89,407.50. Following the sale, the director owned 24,829 shares of the company’s stock, valued at $2,824,298.75. This trade represents a 3.07% decrease in their position. The SEC filing for this sale provides additional information. In the last ninety days, insiders sold 31,766 shares of company stock worth $3,549,706. Corporate insiders own 0.80% of the company’s stock.

Institutional Investors Weigh In On Aflac

Hedge funds have recently made changes to their positions in the company. AQR Capital Management LLC increased its position in Aflac by 1,184.5% during the third quarter. AQR Capital Management LLC now owns 1,264,090 shares of the financial services provider’s stock valued at $141,199,000 after acquiring an additional 1,165,676 shares during the last quarter. Franklin Resources Inc. lifted its holdings in shares of Aflac by 132.4% in the 3rd quarter. Franklin Resources Inc. now owns 1,227,200 shares of the financial services provider’s stock valued at $137,078,000 after acquiring an additional 699,080 shares during the last quarter. Mercer Global Advisors Inc. ADV increased its position in Aflac by 180.5% during the third quarter. Mercer Global Advisors Inc. ADV now owns 252,457 shares of the financial services provider’s stock valued at $27,320,000 after acquiring an additional 565,884 shares during the last quarter. Two Sigma Investments LP increased its stake in Aflac by 402.9% in the third quarter. Two Sigma Investments LP now owns 653,853 shares of the financial services provider’s stock worth $73,035,000 after purchasing an additional 523,845 shares during the period. Finally, Amundi boosted its holdings in shares of Aflac by 11.0% in the third quarter. Amundi now owns 2,631,876 shares of the financial services provider’s stock valued at $297,583,000 after purchasing an additional 261,547 shares during the period. 67.44% of the stock is currently owned by institutional investors.

About Aflac

Aflac Incorporated (American Family Life Assurance Company of Columbus) is a provider of supplemental insurance products designed to help policyholders manage out-of-pocket health care and living expenses. The company underwrites a range of individual and group policies that typically pay cash benefits directly to insureds when covered events occur, enabling greater financial flexibility for medical treatment, hospital stays, critical illness, and related costs. Aflac’s product mix includes supplemental health insurance, life insurance and other specialty coverages intended to complement primary medical plans.

Founded in the mid-20th century and headquartered in Columbus, Georgia, Aflac distributes its products through a combination of employer-sponsored programs, independent brokers and agents, and direct marketing.